Histopathologic Changes in Liver and Renal Tissues Induced by Different Doses of Diclofenac Sodium in Rats

Turkish Journal of Veterinary and Animal Sciences

Volumn 27, Issue 5, 2003, Pages 1131-1140

  Aydin, Gülsen ^a   Gökçimen, Alparslan ^a   Öncü, Meral ^a   Çiçek, Ekrem ^a   Karahan, Nermin ^a   Gökalp, Osman ^a  

^a SULEYMAN DEMIREL UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Diclofenac sodium; Histopathologic changes; Kidney; Liver

Indexed keywords

DICLOFENAC; EOSIN; HEMATOXYLIN; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; CELL DEGENERATION; CELL INFILTRATION; CONTROLLED STUDY; DOSE CALCULATION; DRUG DOSE REGIMEN; EDEMA; HISTOPATHOLOGY; HYPEREMIA; KIDNEY PARENCHYMA; LIVER; LIVER CELL DAMAGE; LIVER HYPERTROPHY; LIVER INJURY; LIVER NECROSIS; LIVER SINUSOID; LIVER TOXICITY; MALE; MONONUCLEAR CELL; NEPHROTOXICITY; NONHUMAN; PORTAL VEIN; RAT; RAT STRAIN; SAMPLING; STAINING; STATISTICAL SIGNIFICANCE; VEIN DILATATION;

ANIMALIA; RATTUS NORVEGICUS;

EID: 0242606267     PISSN: 13000128     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Radwan, M.A.: Zidovudine, diclofenac and ketoprofen pharmacokinetic interactions in rats.: J. Pharm. Pharmacol., 2000; 52: 665-669.
2. Simon, L.S.: Actions and toxic effects of the nonsteroidal anti-inflammatory drugs. Curr. Opin. Rheumatol., 1994; 6: 238-251.
3. Manoukian, A.V., Carson, J.L.: Nonsteroidal anti-inflammatory drug-induced hepatic disorders. Incidence and prevention. Drug Saf., 1996; 15: 64-71.
4. Skoutakis, V.A., Carter, C.A., Mickle, T.R., Smith, V.H., Arkin, C.R., Alissandratos, J., Petty, D.E.: Review of diclofenac and evaluation of its place in therapy as a nonsteroidal anti-inflammatory agent. Drug Intell. Clin. Pharm, 1988; 22: 850-859.
5. Rubatelli, F.F., Chiozza, M.L., Zanardo, V., Cantrutti, F.: Effect on neonate of maternal treatment with indomethacin. J. Pediatr., 1979; 94: 161-165.
6. Kayaalp, S.O.: Rasyonel tedavi yönünden tibbi farmakoloji. Medicine Pharmacology. 8. baski. Ankara., Hacettepe Taş Kitapcilik, Ltd. Şti., pp. 1032-1046, 1998.
7. Gettigan, M. P., Henry, D.: Current problems with non-specific COX inhibitors. Curr. Pharm. Des., 2000; 6: 1693-1724.
8. Menasse, R., Hedwall, P.R., Kraetz, J., Pericin, C., Riesterer, L., Sallmann, A., Ziel, R., Jaques, R.: Pharmacological properties of diclofenac sodium and its metabolites. Scand. J. Rheumatol. Suppl., 1978; 22: 5-16.
9. Zaragoza, M. A., Alfonso, M.V., Roig, C.E.: NSAID-induced hepatotoxicity: aceclofenac and diclofenac. Rev. Esp. Enferm. Dig., 1995; 87: 472-475.
10. Goodman and Gilman's.: Diclofenac Sodium. The Pharmacological Basic of Therapeutics. Ninth Edition. New York., p.: 637, 1995.
11. Castel, J.V., Gomez-Lechon, M.J., Ponsoda, X., Bort, R.: The use of cultured hepatocytes to investigate the mechanism of drug hepatotoxicity. Cell Biol. Toxicol., (Review), 1997; 13: 331-338.
12. Gökçimen, A., Aydin, G., Karaöz, E, Malas, M.A., Öncü, M.: Effect of diclofenac sodium administration during pregnancy in the postnatal period. Fetal Diagn. Ther., 2001; 16: 417-422.
13. Gökçimen, A., Akdoǧan, M., Karaöz, E.: Structural and biochemical changes in liver and renal tissues induced by an acute high dose of diclofenac sodium in rats. Biomed. Res., 2000; 11: 293-302.
14. Kertz-Rommel, D.A., Boelsteri, U.A.: Diclofenac covalent protein binding is dependent on acyl glucuronide formation and is inversely related to P 450-mediated acute cell injury in cultured rat hepatocytes. Toxicol. Appl. Pharmacol., 1993; 120: 155-161.
15. Hargus, S.J., Amouzedeh, H.R., Pumford, N.R.: Metabolic activation and immunochemical localization of liver protein adducts of the nonsteroidal anti-inflammatory drug diclofenac. Chem. Res. Toxicol., 1994; 7: 575-582.
16. Tolman, K.G.: Hepatotoxicity of non-narcotic analgesics. Am. J. Med., (Review)., 1998; 105: 13S-19S.
17. Castel, J.V., Gomez-Lechon, M.J., Ponsoda, X., Bort, R.: The use of cultured hepatocytes to investigate the mechanism of drug hepatotoxicity. Cell Biol. Toxicol., 1997; 13: 331-338.
18. Dunk, A.A., Walt, R.P., Jenkins, W.J., Sherlock, S.S.: Diclofenac hepatitis. Br. Med. J., 1982; 284: 160-166.
19. Sergio, A.U., Antonio, C.S.: Diclofenac sodium and mefenamic acid: Potent inducers of the membrane permeability transition in renal cortex mitochondria. Arch. Biochem. Biophys., 1997; 342: 231-235.
20. Moreno-Sanchez, R., Bravo, C., Vasquez, C., Ayala, G., Silveira, LH., Martinez-Lavin, M.: Inhibition and uncoupling of oxidative phosphorylation by nonsteroidal anti-inflammatory drugs: Study in mitochondria, submitochondrial particles, cells, and whole heart. Biochem. Pharmacol., 1999; 57: 743-752.
21. Bort, R., Ponsoda, X., Jover, R., Gomez-Lechon, M.J., Castell, J.V.: Diclofenac toxicity to hepatocytes: A role for drug metabolism in cell toxicity. J. Pharmacol. Exp. Ther., 1999; 288: 65-72.
22. Brune, K., Lindner, J.: Side effects of anti-inflammatory drugs. In: Inflammation and Drug Therapy Series, 1992; 5: 198-203.
23. Kappus, H.: Overview of enzyme systems involved in bioreduction of drugs and redox cycling. Biochem. Pharmacol., 1986; 35: 1-6.
24. Tang, W., Stearns, R.A., Bandiera, S.M., Zhang, Y., Raab, C., Braun, M.P., Dean, D.C., Pang, J., Leung, K.H., Doss, G.A., Strauss, J.R., Kwei, G.Y., Rushmore, T.H., Chiu, S.H., Baillie, T.A.: Studies on cytochrome P-450-mediated bioactivation of diclofenac in rats and in human hepatocytes: Identification of glutathione conjugated metabolites. Drug Metab. Dispos., 1999; 27: 365-372.
25. Farrell, G.C.: Drug-induced hepatic injury. J. Gastroenterol. Hepatol., 1997; 12: 242-250.
26. Akdoǧan, M., Akkuş, S.: Investigation of erythrocyte antioxidant enzymes activities in high dose diclofenac sodium applied rats. Biomed. Res., 2001; 12: 53-57.
27. Clive, D.M., Stoff, J.S.: Renal syndromes associated with nonsteroidal anti-inflammatory drugs. N. Engl. J. Med., 1984; 310: 563-572.
28. Murray, M.D., Brater, D.C.: Renal toxicity of nonsteroidal anti-inflammatory drugs. Annu. Rev. Pharmacol. Toxicol., 1993; 32: 435-465.
29. Palmer, B.F.: Renal complications associated with use of nonsteroidal anti-inflammatory agents. J. Invest. Med., 1995; 43: 516-553.
30. Abromson, S.B., Weissmann, G.: The mechanism of action of nonsteroidal anti-inflammatory drugs. Arth. Rheum., 1988; 32: 1.
31. Lowry, O.H., Rosebrough, N.J., Randall, R.J.: Protein measurement with the Folin phenol reagent. J. Biol. Chem., 1951; 182: 265-268.
32. Anderson, H.C., Chen, H., Pellet, LT., Tappel, A.L.: Ferous-iron-induced oxidation in chicken liver slices as measured by hemichrome formation and thiobarbituric acid reactive substances: Effect of dietary vitamin E and beta-carotene. Free Radic. Biol. Med., 1993; 15: 35-48.
33. Aebi, H.: Catalase. Methods of enzymatic analysis. In: Beregmeyer, H.U., London, New York, Academic Press, p. 673, 1974.
34. Schmitz, G., Lepper, H., Estler, C.J.: Changes in energy homeostasis and GSH-depletion as possible mechanisms of diclofenac induced cytotoxicity on isolated rat hepatocytes. Naunyn Schmied Eberas. Arch. Pharmacol., 1995; 77: 32-35.
35. Babany, G., Bernuau, J., Danan, G., Rueff, B., Benhamou, J.P.: Hepatite fulminante chez une femme prenant de la glafenine et du dislofenac. Gastroenterol. Clin. Biol., 1985; 9: 185.
36. Castot, A., Netter, P., Arnaudo, J.P.: Pirprofen induced hepatitis with favourable outcome. Therapie, 1984; 3: 297-303.
37. Radford, M.G. Jr., Holley, K.E., Grande, J.P., Larson, T.S., Wagoner, R.D., Donadio, J.V., McCarthy, J.T.: Reversible membranous nephropathy associated with the use of nonsteroidal anti-inflammatory drugs. J. Am. Med. Assoc., 1996; 276: 466-469.
38. 2+ induced membrane transition in mitochondria. I. The protective mechanisms. Arch. Biochem. Biophys, 1979; 195: 453-459.
39. 2+ ions is stimulated byt-butyl hydroperoxide and mediated by reactive oxygen species generated by mitochondria. Free Radical. Biol. Med., 1995; 18: 479-486.
40. 2+ is dependent on mitochondrial generated reactive oxygen species. FEBS Lett., 1996; 378: 150-152.
41. Bernardi, P., Broekemeier, K.M., Pfeiffer, D.R.: Recent progress on regulation of the mitochondrial permeability transition pore, a cyclosporin-sensitive pore in the inner mitochondrial membrane. J. Bioenerg. Biomembr., 1994; 26: 509-517.
42. Mingatto, F.E., Santor, A.C., Uyemura, S.A.: In vitro interaction of nonsteroidal anti-inflammatory drugs on oxidative phosphorylation of rat. Arch. Biochem. Biophy., 1996; 334: 303-308.